Categories
Blog News

MoCRA GMP Delayed Until October 2025: What You Need to Know

MoCRA GMP
The U.S. Food and Drug Administration (FDA) has postponed the implementation of the Modernization of Cosmetics Regulation Act (MoCRA) Good Manufacturing Practices (GMPs) until October 2025.

Originally scheduled for December 29, 2024, this delay offers businesses additional time to prepare for compliance. Here’s what this means for companies navigating MoCRA compliance and how to leverage the extension to stay ahead.

MoCRA, signed into law in December 2022, marked a historic shift in cosmetics regulation by the FDA. Among its key provisions is the requirement for companies to adhere to Good Manufacturing Practices (GMP), ensuring product safety and quality throughout the manufacturing process. The aim is to modernize the cosmetics industry, offering enhanced consumer protections while aligning with global standards.

Why the delay and how it impacts cosmetics companies?

The FDA’s decision to delay MoCRA GMP until October 2025 stems from the need for more detailed regulatory guidance and industry feedback. While the agency works on refining these rules, businesses must still adhere to other MoCRA mandates, such as registration, product listing, and fragrance allergen labeling, which take effect sooner. Key deadlines to watch include the following:

  • Fragrance allergen labeling: Targeted for January 2026.
  • Registration and listing requirements: Enforcement begins mid-2024.

The postponement provides a critical window for companies to:

  1. Assess current practices: Conduct internal audits to evaluate compliance gaps in manufacturing processes.
  2. Develop compliance strategies: Create or update Standard Operating Procedures (SOPs) aligned with anticipated MoCRA GMP requirements.
  3. Invest in training: Educate teams on MoCRA compliance to ensure readiness when enforcement begins.

Steps to Take Now

While the delay grants more time, proactive measures can set your company up for success:

1. Register and List Products Early

Stay ahead by completing your MoCRA registration and product listings before the mid-2024 deadline. These foundational steps are critical to maintaining compliance.

2. Strengthen Documentation

Ensure meticulous record-keeping of manufacturing practices, ingredient sourcing, and testing protocols. These records will be vital once GMP enforcement begins.

3. Monitor FDA Updates

Keep an eye on the FDA’s announcements for the finalized GMP guidelines and adjust your strategies accordingly. Complying with MoCRA GMP standards ahead of schedule not only ensures regulatory readiness but also enhances brand trust and reputation. Companies that prioritize safety and transparency will likely gain a competitive edge in an increasingly regulated market.

Don’t Delay. Prepare Today

The FDA’s extension of the MoCRA GMP deadline provides an invaluable opportunity to get your processes in order. Use this time to ensure your business not only meets regulatory standards but also positions itself as a leader in product safety and quality.

If you’re unsure where to start, Quality Smart Solutions is here to help. Our team of compliance experts specializes in guiding businesses through MoCRA compliance, from registration to certification. Contact us today to ensure your business is prepared to thrive in this new era of cosmetics regulation.

Categories
Blog

What Are FDA Medical Device Classes?

Understanding the FDA classification system for medical devices is key to getting your product to market safely and efficiently. Knowing how the FDA medical devices are categorized can help you avoid setbacks and ensure compliance, whether you’re dealing with a simple tool or a life-saving implant.

But how exactly does the FDA determine a device’s class, and what does it mean for you? Keep reading to uncover the answers and learn how you can navigate the process with confidence.

Why Does the FDA Classify Medical Devices?

The U.S. Food and Drug Administration (FDA) categorizes medical devices into three classes: Class I, II, and III. Each class reflects the device’s risk level and the regulatory controls required to ensure safety and effectiveness.

  • Class I: Low-risk devices with minimal regulatory requirements.
  • Class II: Moderate-risk devices needing unique controls.
  • Class III: High-risk devices requiring premarket approval.

These classifications determine the level of scrutiny your product will face during the FDA approval process. Misunderstanding these classifications can lead to setbacks like penalties, recalls, or approval delays. By the end of this guide, you’ll know exactly where your product fits in the FDA medical devices system.

Class I Medical Devices: Simple and Low Risk

Class I medical devices pose the least risk to patients and are typically simple tools used in daily medical practice. They are common, affordable, and essential in healthcare settings. Class I devices account for nearly half of all FDA medical devices, making them the most common category.

These low-risk tools still require proper compliance to ensure safety for end-users. Some examples of Class I devices include:

  • Bandages and gauze
  • Examination gloves
  • Surgical sponges
  • Hand-held surgical instruments like forceps
  • Basic thermometers (non-electronic)

While most Class I devices are exempt from Premarket Notification (510(k)), they must meet General Controls, such as proper labelling, record-keeping, and adherence to quality system regulations.

Class II Medical Devices: Moderate Risk and Special Controls

Class II medical devices present a moderate risk to patients and healthcare providers. They require more oversight than Class I devices to ensure consistent safety and performance.

This classification makes up about 43% of all FDA medical devices, playing a critical role in diagnostics, treatment, and patient care while maintaining manageable risk levels. Examples include:

  • Blood pressure monitors
  • Syringes (non-automated)
  • Infusion pumps
  • Catheters
  • Ultrasound imaging tools
  • Powered wheelchairs

To achieve compliance, most Class II devices require Premarket Notification (510(k)) to demonstrate equivalence to an already-approved product. Additional Special Controls may apply, such as performance testing, labelling requirements, and post-market monitoring.

Class III Medical Devices: High Risk and Highly Regulated

Class III medical devices are critical for sustaining life, preventing serious health issues, or addressing significant risks if they malfunction. Due to their life-critical nature, these devices undergo the most rigorous testing and regulatory scrutiny.

Although Class III devices represent a smaller percentage of FDA medical devices, their impact is substantial. Examples of Class III devices include:

  • Pacemakers
  • Implantable defibrillators
  • Heart valves
  • Cochlear implants
  • Artificial joints like hip or knee replacements
  • Stents for heart or vascular conditions

Approval for Class III devices requires Premarket Approval (PMA), which involves extensive clinical testing to prove safety and efficacy. After approval, ongoing post-market monitoring is necessary to identify any long-term risks or complications.

How to Identify Your Medical Device’s Class

Knowing where your product fits will save time, reduce errors, and ensure you complete the right approval process. It starts with understanding the FDA’s system and comparing your product to similar devices that have already been approved.

  1. Define the intended use: What does your device do, and who will use it?
  2. Assess the risk level: Consider the potential harm if the device malfunctions.
  3. Check FDA databases: Look up similar devices in the FDA medical devices Product Classification Database.
  4. Prepare the right submission: Based on the class, complete a 510(k) notification or PMA application.

When in doubt, consulting regulatory experts can save you time and ensure your device meets all FDA medical devices requirements.

Simplify Your Compliance Journey

Navigating the FDA classification system for medical devices doesn’t have to be overwhelming. By understanding the differences between Class I, II, and III medical devices, you can take the right steps to bring your product to market faster and safer.

Need help identifying your device’s classification and managing submissions? Reach out to our team for expert support and guidance in complying with FDA medical devices standards.

Categories
Blog

VHP Representative vs. Importer of Record: Key Differences

A veterinarian giving a pet multivitamins, representing compliance with Canadian veterinary health product (VHP) regulations.If you’re planning to bring veterinary health products (VHPs) into Canada, you’ve probably come across the terms VHP Canadian representative and VHP Importer of Record. Sounds technical, right? But don’t worry, it’s not as complicated as it seems! These roles may sound similar, but they have distinct responsibilities that are essential to your success in the Canadian market.

Understanding the differences between these two roles can save you a lot of time, money, and stress. To help you navigate these requirements with confidence, we’ve broken it all down for you. Keep reading to discover what these roles are all about and why you need both for smooth operations.

What is a VHP Canadian Representative?

A VHP Canadian representative is your trusted partner when it comes to meeting Canadian regulations. If you’re a foreign manufacturer selling VHPs in Canada, this role isn’t optional, it’s required. Essentially, they’re your regulatory guide, helping you navigate the rules and acting as your main contact with Health Canada. Their key responsibilities include:

  • Liaising with Health Canada regarding product registration.
  • Assisting in maintaining compliance with Canadian VHP regulations.
  • Addressing any queries or concerns related to product safety.

With a knowledgeable Canadian representative on your side, you’ll save time and avoid potential issues. Plus, they make it easier for you to focus on other parts of your business.

What is a VHP Importer of Record?

In contrast, the VHP Importer of Record is responsible for ensuring that products entering Canada meet all importation requirements. This individual or entity facilitates customs clearance and ensures compliance with Canadian import regulations. Responsibilities include:

  • Handling customs documentation and declarations.
  • Ensuring that imported VHPs meet Canadian standards.
  • Managing duties, taxes, and other import-related fees.

In other words, they’re the ones who make sure your products get from point A to point B without any hiccups.

How Do These Roles Work Together?

Although the VHP Canadian representative and VHP Importer of Record have separate responsibilities, they complement each other perfectly. A VHP Canadian representative acts as the liaison between the foreign manufacturer and Health Canada, ensuring product compliance and addressing regulatory concerns.

On the other hand, a VHP Importer of Record is responsible for managing the logistics and legalities of bringing VHPs into Canada, including customs clearance and meeting importation standards.

By working together, these roles ensure that both regulatory and logistical aspects are covered, giving you peace of mind and allowing you to focus on growing your business.

In essence, for a smooth and compliant entry into the Canadian market, both roles are essential, and without them, your business risks operational setbacks.

Partner with Quality Smart Solutions

At Quality Smart Solutions, we specialize in supporting VHP manufacturers and importers navigate the complexities of the Canadian regulatory landscape. By partnering with us, you can focus on growing your business while we handle the regulatory details.

Ready to simplify your Canadian operations? Explore our VHP services for Canada or contact us today to get started!

Categories
Blog

How to Sell NHPs on Amazon Canada: A Complete Guide

Herbal remedies are classified as natural health productsSelling natural health products (NHPs) on Amazon Canada is a lucrative opportunity to expand your business and reach millions of potential customers. However, navigating the process requires understanding and adhering to Canadian regulations, as well as Amazon’s specific policies for NHPs.

From securing the necessary approvals to optimizing your product listings and driving sales, there are key steps to ensure your success. In this guide, we’ll walk you through everything you need to know to get your NHP listed and start selling successfully. Keep reading to unlock actionable tips and insights.

Understanding NHP Regulations in Canada

Before you can sell your NHP on Amazon Canada, it must meet Health Canada’s regulatory requirements. Every NHP sold in Canada requires a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) to confirm it’s safe, effective, and properly labeled. Obtaining an NPN might seem complex, but by following these steps, you can navigate the process with confidence:

  1. Submit an application: Use Health Canada’s Natural Health Products Online System (NHP Online) to apply for your NPN.
  2. Provide evidence: Include supporting data, such as ingredient safety, dosage, and proposed health claims.
  3. Approval process: Once approved, you’ll receive your NPN, allowing you to legally sell your product in Canada.

Setting Up Your Amazon Canada Seller Account

After obtaining your NPN, it’s time to create your Amazon Canada seller account. Choose between Individual or Professional plans, depending on your sales volume. To streamline your process, consider these key points:

  • Category approval: Apply for approval to sell in the NHP category. Amazon requires documentation, such as your NPN and product labels.
  • UPC/EAN codes: Ensure your product has valid barcodes for Amazon listings.
  • Shipping and fulfillment: Decide whether to handle logistics yourself or use Fulfillment by Amazon (FBA) for faster delivery and Prime eligibility.

Optimize Your NHP Listings

Your Amazon product listing is the cornerstone of your online sales strategy. It’s not just about informing potential customers but also about convincing them to buy. Start by incorporating relevant keywords in your product title and description. These could include terms like “Natural Health Products,” “Health Canada Approved,” and specific benefits of your product.

It’s also essential to emphasize your product’s unique features, such as organic ingredients or eco-friendly packaging. Pair these descriptions with high-quality images that present your product from various angles. For added impact, ensure the images look professional and include alt text, such as: “Natural health product approved by Health Canada.”

Staying Compliant with Amazon and Health Canada

Maintaining compliance is crucial to avoid penalties or account suspension. Here’s what to watch for:

  • Label accuracy: Ensure all labels meet Health Canada’s standards, including proper ingredient lists and claims.
  • Inventory management: Monitor stock levels and expiration dates to prevent customer complaints.
  • Customer feedback: Respond promptly to reviews and questions to build trust and improve your ratings.

Driving Sales With Marketing

After setting up your product listing, marketing becomes the key to driving traffic and boosting sales. Consider leveraging Amazon Ads to target customers searching for products like yours. Sponsored Product Ads can place your listing at the top of search results, giving you greater visibility.

Another effective strategy is to optimize your product descriptions regularly by integrating trending keywords. Beyond Amazon, social media campaigns can further amplify your reach. Platforms like Instagram and Facebook are excellent for showcasing your product and connecting with potential buyers.

How We Can Help

Selling NHPs on Amazon Canada doesn’t have to be overwhelming. With the right preparation and strategies, you can turn this opportunity into a profitable venture. At Quality Smart Solutions, we specialize in helping businesses like yours navigate Health Canada regulations, optimize Amazon listings, and implement effective marketing campaigns. Contact us today or explore our NHP compliance services to get started on your journey to success.

Categories
Blog News

Health Canada Fees 2025 Guide

Canadian flag symbolizing Health Canada Fees 2025 and regulatory compliance.Are you ready for the upcoming changes to Health Canada Fees in 2025? These fees, effective from April 2025, impact businesses dealing with drugs, medical devices, and cannabis. With updates spanning licensing, submissions, and compliance requirements, staying informed is key to avoiding disruptions.

Health Canada is introducing a phased fee structure that ensures businesses contribute to maintaining high standards for product safety and efficacy. From updated pre-market evaluation fees for drugs and medical devices to regulatory costs for cannabis producers, these changes could affect your budget and planning.

Want to know how these updates might impact your operations? Keep reading to explore the details and learn how to navigate these fees effectively with expert tips from Quality Smart Solutions.

Medical Devices

If you’re in the medical device sector, you will encounter fees tied to your initial Medical Device License (MDL) Application. These fees vary based on the classification of your medical device. The following are the fees for an MDL application as of April 1, 2025:

  • Class 2 Devices: $632
  • Class 3 Devices: $13,926
  • Class 3 Devices (Near Patient): $29,664
  • Class 4 Devices: $30,199

Applicable MDL amendments are also subject to additional application fees.

If you wish to apply for a Medical Device Establishment License (MDEL), you will need to pay both the initial application fee and the annual license renewal fee each year. The following are MDEL fees as of April 1, 2025.

  • Application for a new MDEL and annual review of license: $5426

Annual fees for right to sell licensed devices also apply. The fee as of April 1, 2025 is $452. These fees support ongoing regulatory oversight, ensuring that devices meet safety and compliance standards.

Drugs (Drug Identification Number Registration)

For drugs for human use requiring a Drug Identification Number (DIN), Health Canada has detailed fees based on the type of submission:

  • New Active Substance: $606,286
  • Clinical and Non-Clinical Data with Chemistry: $313,944
  • Comparative Studies Only$70,750
  • Administrative Submissions: $1,002
  • Labelling only: $6,328
  • Disinfectant – Full review: $13,186
  • Drug identification number application – Labelling standards: $1,912

These fees cover the rigorous evaluation process, ensuring products meet Health Canada’s stringent standards.

Additionally, companies engaged in various activities must hold a Drug Establishment License (DEL) which requires annual renewal. Fees are determined by the scope of activities and the types of products handled. The DEL fees for 2025 are:

  • Fabrication – Sterile dosage form: $49,558
  • Importation: $38,265
  • Fabrication – Non-sterile dosage form: $36,740
  • Distribution: $19,531
  • Wholesaling: $11,398
  • Packaging/labelling: $7,164
  • Testing: $5,913
  • Building outside Canada (each): $1,088

DEL fees ensure that establishments meet Good Manufacturing Practices (GMP) standards, supporting the safety and quality of pharmaceutical products in Canada.

For drugs already holding a Drug Identification Number (DIN), companies are required to pay an annual “Right to Sell” fee. The fee are as follows:

  • Human drugs – Disinfectant: $1,730
  • Human drugs – Non-prescription: $3,334
  • Human drugs – Prescription: $5,531

These fees enable ongoing compliance monitoring and market authorization renewal.

Cannabis

For businesses operating in Canada’s cannabis industry, Health Canada Fees cover several areas, including application screening, security clearance, and regulatory oversight. As of now, Health Canada has not published updated cannabis-related fees for the fiscal year 2025-2026. The most recent fee adjustments, effective April 1, 2024, are as follows:

  • Application Screening Fee: $3,933 for a standard-level license or sale for medical purposes and $1,969 for a micro-level license.
  • Security Clearance Fee: $1,987 per individual requiring clearance.
  • Annual Regulatory Fee:
    • Micro Cultivator: If the cannabis revenue is $1 million or less, the greater of 1% of the cannabis revenue, and $2,500 OR if the cannabis revenue is greater than $1 million, the maximum amount plus 2.3% of the amount by which the cannabis revenue exceeds $1 million.
    • Standard Cultivator: The greater of 2.3% of gross revenue or a minimum of $23,000.

Navigating these fees is critical for maintaining compliance and ensuring uninterrupted operations.

Why It Matters

Missing deadlines or miscalculating Health Canada fees can lead to costly delays or penalties. By planning ahead and leveraging expert guidance, you can focus on what matters most: growing your business.

Regulatory compliance doesn’t have to be daunting. At Quality Smart Solutions, we provide expert guidance to help you stay informed and save money. Explore more about our services to see how we can support your regulatory journey.

For a complete overview of all fees, visit Health Canada’s Funding and Fees page$1,002$36,740$3,334

Subscribe to global regulatory updates

We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.